Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
Fosmanogepix IV infusion
1 trial
phase_3
basilea-pharmaceutica-international-ag-allschwil
Standard of care antifungal therapy
1 trial
phase_3
basilea-pharmaceutica-international-ag-allschwil
2 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06925321Phase 3Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
StudydirectorStart date: 2025-08-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

1 similar investigators found

Frederic Lamoth

Centre Hospitalier Universitaire Vaudois

Related
1 trials

Shared therapeutic areas:

Invasive Mold Infections
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06925321Phase 3StudyDirector

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Invasive Mold Infections
Recruiting

All 1 trials loaded